{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:45:10Z","timestamp":1791859510997,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08620-1","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:33:38Z","timestamp":1784230418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic immune profiling of heterologous versus homologous boosting of COVID-19 vaccination"],"prefix":"10.1186","volume":"24","author":[{"given":"Xu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudachuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-5151","authenticated-orcid":false,"given":"Jingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"3","key":"8620_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41591-022-01704-7","volume":"28","author":"SMS Cheng","year":"2022","unstructured":"Cheng SMS, Mok CKP, Leung YWY, Ng SS, Chan KCK, Ko FW, et al. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nat Med. 2022;28(3):486\u201389. https:\/\/doi.org\/10.1038\/s41591-022-01704-7.","journal-title":"Nat Med"},{"key":"8620_CR2","doi-asserted-by":"publisher","unstructured":"Mok CKP, Chen C, Zhao S, Sun Y, Yiu K, Chan T-O, et al. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study. Lancet Microbe. 2023;4(6):e418\u201330. https:\/\/doi.org\/10.1016\/S2666-5247(23)00006-X.","DOI":"10.1016\/S2666-5247(23)00006-X"},{"issue":"3","key":"8620_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1056\/NEJMc2206900","volume":"387","author":"X Zhao","year":"2022","unstructured":"Zhao X, Zhang R, Qiao S, Wang X, Zhang W, Ruan W, et al. Omicron SARS-CoV-2 neutralization from inactivated and ZF2001 vaccines. N Engl J Med. 2022;387(3):277\u201380. https:\/\/doi.org\/10.1056\/NEJMc2206900.","journal-title":"N Engl J Med"},{"key":"8620_CR4","unstructured":"World Health Organization. Highlights from the meeting of the strategic advisory group of experts (SAGE) on immunization. 2021. https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/sage\/2021\/october\/sage_oct2021_meetinghighlights.pdf?sfvrsn=3dcae610_11."},{"key":"8620_CR5","unstructured":"World Health Organization. Interim recommendations for heterologous COVID-19 vaccine schedules. 2022. https:\/\/www.who.int\/news\/item\/16-12-2021-interim-recommendations-for-heterologous-covid-19-vaccine-schedules."},{"issue":"2","key":"8620_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41591-021-01677-z","volume":"28","author":"J Li","year":"2022","unstructured":"Li J, Hou L, Guo X, Jin P, Wu S, Zhu J, et al. Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Nat Med. 2022;28(2):401\u201309. https:\/\/doi.org\/10.1038\/s41591-021-01677-z.","journal-title":"Nat Med"},{"key":"8620_CR7","unstructured":"World Health Organization. WHO validates 11th vaccine for COVID-19. 19, May, 2022. Available online: https:\/\/www.who.int\/news\/item\/19-05-2022-who-validates-11th-vaccine-for-covid-19. 9, November, 2023."},{"key":"8620_CR8","unstructured":"Network CG. State council joint Prevention and Control mechanism Press conference: China launches heterogenous boost immunization, 19 February 2022. Available online: http:\/\/www.gov.cn\/xinwen\/2022-02\/19\/content_5674 688.htm."},{"key":"8620_CR9","doi-asserted-by":"publisher","first-page":"1461419","DOI":"10.3389\/fimmu.2024.1461419","volume":"15","author":"H Zheng","year":"2024","unstructured":"Zheng H, Li C, Zheng X, Jiang HD, Li Y, Yao A, et al. Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19. Front. Immunol. 2024;15:1461419. https:\/\/doi.org\/10.3389\/fimmu.2024.1461419.","journal-title":"Front. Immunol"},{"key":"8620_CR10","doi-asserted-by":"publisher","unstructured":"Jin P, Guo X, Chen W, Ma S, Pan H, Dai L, et al. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia\/ZF2001): a randomized, observer-blinded, placebo-controlled trial. PLoS Med. 2022;19(5):e1003953. https:\/\/doi.org\/10.1371\/journal.pmed.1003953.","DOI":"10.1371\/journal.pmed.1003953"},{"issue":"9","key":"8620_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S1473-3099(23)00199-8","volume":"23","author":"JD Wu","year":"2023","unstructured":"Wu JD, Li JX, Liu J, Wang HM, Zhou GH, Li J, et al. Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged \u226518 years: a randomised, double-blind, phase 2b trial. The Lancet Infect Dis. 2023;23(9):1020\u201330. https:\/\/doi.org\/10.1016\/S1473-3099(23)00199-8.","journal-title":"The Lancet Infect Dis"},{"key":"8620_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.imlet.2022.08.006","volume":"249","author":"J Ma","year":"2022","unstructured":"Ma J, Bai H, Gong T, Mao W, Nie Y, Zhang X, et al. Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations. Immunol Lett. 2022;249:23\u201332. https:\/\/doi.org\/10.1016\/j.imlet.2022.08.006.","journal-title":"Immunol Lett"},{"issue":"6504","key":"8620_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, et al. A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2. Science. 2020;369(6504):650\u201355. https:\/\/doi.org\/10.1126\/science.abc6952.","journal-title":"Science"},{"key":"8620_CR14","unstructured":"Zhang L, Cao L, Gao X-S, Zheng B-Y, Deng Y-Q, Li J-X, et al. A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2. Natl Sci Rev. 2021;8(8)."},{"issue":"6","key":"8620_CR15","doi-asserted-by":"publisher","first-page":"117439","DOI":"10.1016\/j.celrep.2026.117439","volume":"45","author":"K Dueker","year":"2026","unstructured":"Dueker K, Capozzola T, Feng Z, Lin RN, Hurtado J, Bangaru S, et al. Heterologous betacoronavirus spike immunization in non-human primates elicits antibodies that neutralize both sarbeco- and merbecoviruses. Cell Rep. 2026;45(6):117439. https:\/\/doi.org\/10.1016\/j.celrep.2026.117439.","journal-title":"Cell Rep"},{"key":"8620_CR16","doi-asserted-by":"publisher","first-page":"105428","DOI":"10.1016\/j.ebiom.2024.105428","volume":"110","author":"Y Li","year":"2024","unstructured":"Li Y, Qin S, Dong L, Xiao Y, Zhang Y, Hou Y, et al. Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineages. EBioMedicine. 2024;110:105428. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105428.","journal-title":"EBioMedicine"},{"key":"8620_CR17","doi-asserted-by":"publisher","unstructured":"Vlachonikola E, Pechlivanis N, Karakatsoulis G, Degano M, Psomopoulos F, Crisanti A, et al. Imprints of somatic hypermutation on B-cell receptor immunoglobulins post-infection versus post-vaccination against SARS-CoV-2. Immunohorizons. 2025, 30;9(7):vlaf021. https:\/\/doi.org\/10.1093\/immhor\/vlaf021.","DOI":"10.1093\/immhor\/vlaf021"},{"issue":"8062","key":"8620_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41586-025-08728-2","volume":"641","author":"J Merkenschlager","year":"2025","unstructured":"Merkenschlager J, Pyo AGT, Silva Santos GS, Schaefer-Babajew D, Cipolla M, Hartweger H, et al. Regulated somatic hypermutation enhances antibody affinity maturation. Nature. 2025;641(8062):495\u2013502. https:\/\/doi.org\/10.1038\/s41586-025-08728-2.","journal-title":"Nature"},{"issue":"1","key":"8620_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41421-023-00585-5","volume":"9","author":"S Guo","year":"2023","unstructured":"Guo S, Zheng Y, Gao Z, Duan M, Liu S, Du P, et al. Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine. Cell Discov. 2023;9(1):79. https:\/\/doi.org\/10.1038\/s41421-023-00585-5.","journal-title":"Cell Discov"},{"issue":"7","key":"8620_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41590-021-00936-y","volume":"22","author":"D Chen","year":"2021","unstructured":"Chen D, Wang Y, Manakkat Vijay GK, Fu S, Nash CW, Xu D, et al. Coupled analysis of transcriptome and BCR mutations reveals role of OXPHOS in affinity maturation. Nat Immunol. 2021;22(7):904\u201313. https:\/\/doi.org\/10.1038\/s41590-021-00936-y.","journal-title":"Nat Immunol"},{"issue":"1","key":"8620_CR21","doi-asserted-by":"publisher","first-page":"10566","DOI":"10.1038\/s41467-025-65596-0","volume":"16","author":"M Xie","year":"2025","unstructured":"Xie M, Qiu Y, Zhao X, Shi J, Liu Y, Zhang Q, et al. Orphan broadly RBD-binding antibodies annotate three remaining conserved RBD epitopes along SARS-CoV-2 evolution. Nat Commun. 2025;16(1):10566. https:\/\/doi.org\/10.1038\/s41467-025-65596-0.","journal-title":"Nat Commun"},{"key":"8620_CR22","doi-asserted-by":"publisher","first-page":"105439","DOI":"10.1016\/j.ebiom.2024.105439","volume":"110","author":"T Kuwata","year":"2024","unstructured":"Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, et al. Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case. eBiomedicine. 2024;110:105439. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105439.","journal-title":"eBiomedicine"},{"issue":"6507","key":"8620_CR23","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1126\/science.abd2321","volume":"369","author":"M Yuan","year":"2020","unstructured":"Yuan M, Liu H, Wu NC, Lee C-CD, Zhu X, Zhao F, et al. Structural basis of a shared antibody response to SARS-CoV-2. Science. 2020;369(6507):1119\u201323. https:\/\/doi.org\/10.1126\/science.abd2321.","journal-title":"Science"},{"issue":"1","key":"8620_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-020-00287-4","volume":"5","author":"F Fagiani","year":"2020","unstructured":"Fagiani F, Catanzaro M, Lanni C. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2. Sig Transduct Target Ther. 2020;5(1):170. https:\/\/doi.org\/10.1038\/s41392-020-00287-4.","journal-title":"Sig Transduct Target Ther"},{"key":"8620_CR25","doi-asserted-by":"publisher","unstructured":"Jin X, Zhou W, Luo M, Wang P, Xu Z, Ma K, et al. Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing. Briefings Bioinf. 2021;22(6):bbab192. https:\/\/doi.org\/10.1093\/bib\/bbab192.","DOI":"10.1093\/bib\/bbab192"},{"issue":"6","key":"8620_CR26","doi-asserted-by":"publisher","first-page":"114265","DOI":"10.1016\/j.celrep.2024.114265","volume":"43","author":"B Liu","year":"2024","unstructured":"Liu B, Niu X, Deng Y, Zhang Z, Wang Y, Gao X, et al. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike. Cell Rep. 2024;43(6):114265. https:\/\/doi.org\/10.1016\/j.celrep.2024.114265.","journal-title":"Cell Rep"},{"issue":"6556","key":"8620_CR27","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abh1139","volume":"373","author":"M Yuan","year":"2021","unstructured":"Yuan M, Huang D, Lee C-CD, Wu NC, Jackson AM, Zhu X, et al. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science. 2021;373(6556):818\u201323. https:\/\/doi.org\/10.1126\/science.abh1139.","journal-title":"Science"},{"issue":"9","key":"8620_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","volume":"21","author":"J-Y Zhang","year":"2020","unstructured":"Zhang J-Y, Wang X-M, Xing X, Xu Z, Zhang C, Song J-W, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21(9):1107\u201318. https:\/\/doi.org\/10.1038\/s41590-020-0762-x.","journal-title":"Nat Immunol"},{"issue":"1","key":"8620_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41421-021-00321-x","volume":"7","author":"L Luo","year":"2021","unstructured":"Luo L, Liang W, Pang J, Xu G, Chen Y, Guo X, et al. Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals. Cell Discov. 2021;7(1):89. https:\/\/doi.org\/10.1038\/s41421-021-00321-x.","journal-title":"Cell Discov"},{"key":"8620_CR30","doi-asserted-by":"publisher","unstructured":"Sureshchandra S, Lewis SA, Doratt BM, Jankeel A, Coimbra Ibraim I, Messaoudi I. Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine. JCI Insight. 2021;6(24):e153201. https:\/\/doi.org\/10.1172\/jci.insight.153201.","DOI":"10.1172\/jci.insight.153201"},{"key":"8620_CR31","doi-asserted-by":"publisher","first-page":"1758642","DOI":"10.3389\/fimmu.2026.1758642","volume":"17","author":"Y Aritsu","year":"2026","unstructured":"Aritsu Y, Kitabatake M, Kurose A, Hamana H, Nakama T, Yamada K, et al. N-terminal pyroglutamylation of an HLA-A24-restricted immunodominant epitope enhances SARS-CoV-2-specific T-cell responses. Front. Immunol. 2026;17:1758642. https:\/\/doi.org\/10.3389\/fimmu.2026.1758642.","journal-title":"Front. Immunol"},{"issue":"1","key":"8620_CR32","doi-asserted-by":"publisher","first-page":"44661","DOI":"10.1038\/srep44661","volume":"7","author":"YF Fuchs","year":"2017","unstructured":"Fuchs YF, Eugster A, Dietz S, Sebelefsky C, K\u00fchn D, Wilhelm C, et al. CD8+ T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage. Sci Rep. 2017;7(1):44661. https:\/\/doi.org\/10.1038\/srep44661.","journal-title":"Sci Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08620-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08620-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08620-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:24Z","timestamp":1791856104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08620-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8620"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08620-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol and informed consent were reviewed and approved by the Ethics Committee of the Jiangsu Center for Disease Control and Prevention before the launch of the trial, and no changes were made to the protocol after the study began. All procedures in this study were conducted in accordance with the ethical standards of national research committees and fully adhered to the principles of Helsinki. Ethics Approval Number: JSJK2021-A007-01.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1293"}}